Caxton Associates LP Enanta Pharmaceuticals Inc Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $199,930 - $398,959	18,028 New	18,028 $201,000
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $527,833 - $1.06 Million	13,843 New	13,843 $654,000
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $184,129 - $238,289	-2,815 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$85.46 - $126.37 $42,388 - $62,679	-496 Reduced 14.98%	2,815 $241,000
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $191,740 - $305,108	3,311 New	3,311 $268,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.